Inactivation of plasma alpha1-proteinase inhibitor by aldehydes found in cigarette smoke.
Authors
Gan JC; Ansari GA
Source
SAAS Bull: Biochem Biotechnol 1990 Jan; 3:32-36
Link
NIOSHTIC No.
00233251
Abstract
The effects of some carbonyl compounds found in cigarette smoke on the proteinase inhibitory activity of alpha1-proteinase-inhibitor (API) and unfractionated plasma were investigated. When API was incubated with increasing concentrations of acrolein (107028) for up to 120 minutes, elastase inhibitory capacity (EIC) and trypsin inhibitory capacity (TIC) were reduced. About 35% and 75% of EIC were lost at acrolein concentrations of 10 millimolar (mM) and 40mM, respectively. Increasing acrolein to 100mM resulted in total loss of EIC instantaneously. The rate of loss of TIC was similar to EIC, but the decrease in EIC was greater. Whole plasma reacted with acrolein showed a decrease of 50% and 60% for TIC and EIC, respectively, at 100mM acrolein. When API was incubated with pyruvic-aldehyde, 10% of EIC and TIC were lost. It required 400mM pyruvic-aldehyde (78988) to inactivate API 90% in plasma. Incubation of API with 200mM glyoxal (107222) caused 25 to 30% loss of EIC or TIC. In whole plasma, 500mM glyoxal caused 15% reduction in EIC and 30% reduction of TIC. Loss of EIC by acrolein was dependent on disappearance of lysine and histidine residues, which was in turn dependent on concentration of acrolein. The authors conclude that all three aldehydes inactivated API, with acrolein being the most potent. The findings suggest that aldehydes may play a role in pulmonary emphysema, which results from the proteolytic action of elastases on lung elastin.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.